Total Funding
31
48
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
67123
76Bio is a biotechnology company that develops therapies for patients with life-threatening diseases.
- Christopher Wilfong: Co-Founder, President & CEOPast Role: Trustbridge Partners, Director
K. Dane Wittrup: Co-FounderPast Role: Massachusetts Institute of Technology, Associate Director
About the Company
76Bio is a biotechnology company that develops therapies for patients with life-threatening diseases. It specializes in pioneering targeted protein degraders.
The company was founded in 2020 and is based in New York.
